AAAAAA
Results:
1-13
|
Results: 13
Authors:
HABERMANN E
Citation: E. Habermann, POISON AND NOCEBO - 2 ASPECTS OF TOXICOLO GY, Medizinische Klinik, 93(2), 1998, pp. 113-118
Authors:
VONEICHELSTREIBER C
HERINGDORF DMZ
HABERMANN E
SARTINGEN S
Citation: C. Voneichelstreiber et al., CLOSING IN ON THE TOXIC DOMAIN THROUGH ANALYSIS OF A VARIANT CLOSTRIDIUM-DIFFICILE CYTOTOXIN-B, Molecular microbiology, 17(2), 1995, pp. 313-321
Authors:
HAUSINGER A
VOLKNANDT W
ZIMMERMANN H
HABERMANN E
Citation: A. Hausinger et al., INHIBITION BY CLOSTRIDIAL NEUROTOXINS OF CALCIUM-INDEPENDENT [H-3] NORADRENALINE OUTFLOW FROM FREEZE-THAWED SYNAPTOSOMES - COMPARISON WITH SYNAPTOBREVIN HYDROLYSIS, Toxicon, 33(11), 1995, pp. 1519-1530
Authors:
HOFMANN F
HERRMANN A
HABERMANN E
VONEICHELSTREIBER C
Citation: F. Hofmann et al., SEQUENCING AND ANALYSIS OF THE GENE ENCODING THE ALPHA-TOXIN OF CLOSTRIDIUM-NOVYI PROVES ITS HOMOLOGY TO TOXIN-A AND TOXIN-B OF CLOSTRIDIUM-DIFFICILE, MGG. Molecular & general genetics, 247(6), 1995, pp. 670-679
Authors:
HABERMANN E
Citation: E. Habermann, DRUG THERAPEUTICS - HOW SCIENTIFIC ARE TH EY, Die medizinische Welt, 46(1), 1995, pp. 1-7
Authors:
HABERMANN E
Citation: E. Habermann, EDUCATION IN PHARMACOLOGY - COMMENT, Trends in pharmacological sciences, 15(6), 1994, pp. 175-176
Authors:
HABERMANN E
Citation: E. Habermann, COMMENTS FROM THE ASSOCIATION OF GERMAN CLINICAL PHARMACOLOGISTS - REPLY, Trends in pharmacological sciences, 15(11), 1994, pp. 411-411
Authors:
HUNT JM
BOMMERT K
CHARLTON MP
KISTNER A
HABERMANN E
AUGUSTINE GJ
BETZ H
Citation: Jm. Hunt et al., POST-DOCKING ROLE FOR SYNAPTOBREVIN IN SYNAPTIC VESICLE FUSION, Neuron, 12(6), 1994, pp. 1269-1279
Authors:
VOLCHUK A
MITSUMOTO Y
HE LJ
LIU Z
HABERMANN E
TRIMBLE W
KLIP A
Citation: A. Volchuk et al., EXPRESSION OF VESICLE-ASSOCIATED MEMBRANE-PROTEIN 2 (VAMP-2) SYNAPTOBREVIN-II AND CELLUBREVIN IN RAT SKELETAL-MUSCLE AND IN A MUSCLE-CELL LINE, Biochemical journal, 304, 1994, pp. 139-145
Authors:
GRISSO JA
KELSEY JL
STROM BL
OBRIEN LA
MAISLIN G
LAPANN A
SAMELSON L
HOFFMAN S
ANTHONY J
HIBBERD A
CLANCY M
COTLER J
DELONG W
ECKER M
FRIEDENBERG ZB
GOOD R
HUMMER C
JUNKIN D
MARKMAN W
MOOAR P
STEIN H
WOHL M
WYNNE B
ZASLOW D
ANDREWS D
PAVILION A
DICK H
HABERMANN E
INSLER H
MENEZES P
ROSENTHAL R
SADLER A
SHELTON M
TEICHER J
ZICKEL R
Citation: Ja. Grisso et al., RISK-FACTORS FOR HIP FRACTURE IN BLACK-WOMEN, The New England journal of medicine, 330(22), 1994, pp. 1555-1559
Authors:
SCHEINERBOBIS G
HERINGDORF DMZ
CHRIST M
HABERMANN E
Citation: G. Scheinerbobis et al., PALYTOXIN INDUCES K-CELLS EXPRESSING THE MAMMALIAN SODIUM-PUMP( EFFLUX FROM YEAST), Molecular pharmacology, 45(6), 1994, pp. 1132-1136
Authors:
KISTNER A
SANDERS D
HABERMANN E
Citation: A. Kistner et al., DISULFIDE FORMATION IN REDUCED TETANUS TOXIN BY THIOREDOXIN - THE PHARMACOLOGICAL ROLE OF INTERCHAIN COVALENT AND NONCOVALENT BONDS, Toxicon, 31(11), 1993, pp. 1423-1434
Authors:
FAIRWEATHER NF
SANDERS D
SLATER D
HUDEL M
HABERMANN E
WELLER U
Citation: Nf. Fairweather et al., PRODUCTION OF BIOLOGICALLY-ACTIVE LIGHT-CHAIN OF TETANUS TOXIN IN ESCHERICHIA-COLI - EVIDENCE FOR THE IMPORTANCE OF THE C-TERMINAL 16 AMINO-ACIDS FOR FULL BIOLOGICAL-ACTIVITY, FEBS letters, 323(3), 1993, pp. 218-222
Risultati:
1-13
|